drugset

drugset / Trial / NCT00767637

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

NCT00767637 ↗

Phase 2 Completed 14 enrolled Bayer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis

Timeline

Start: 2005-06
Primary completion: 2008-10
Completion: 2008-10

Publications

Shigematsu T, Tokumoto A, Nakaoka A, Arisaka H. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia. Ther Apher Dial. 2011 Apr;15(2):176-84. doi: 10.1111/j.1744-9987.2010.00898.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lanthanum Carbonate	Other / unclassified	750 mg	—

Indications